Skip to content

Clinical trials

Phase 4 Myocardial Infarction trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 4 Country / region: France Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20092
20101
20112
20151
20171
20181
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris3
AstraZeneca1
Baim Institute for Clinical Research1
Boehringer Ingelheim1
Central Hospital, Nancy, France1
Centre Hospitalier de PAU1
KU Leuven1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
University Hospital, Caen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction11
Acute Coronary Syndrome3
Coronary Artery Disease3
Myocardial Ischemia2
Shock, Cardiogenic2
Atrial Fibrillation1
Cardiovascular Diseases1
Heart Diseases1
Stroke1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.